Taysha Gene Therapies (TSHA) News Today → Central Banks Preparing for US Dollar Collapse? (From Behind the Markets) (Ad) Free TSHA Stock Alerts $3.17 +0.11 (+3.59%) (As of 03/27/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTaysha Gene Therapies (NASDAQ:TSHA) Trading Down 2.6%marketbeat.com - March 26 at 12:59 PMTaysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Consensus Rating of "Buy" by Analystsamericanbankingnews.com - March 26 at 5:18 AMTaysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of "Buy" by Analystsmarketbeat.com - March 26 at 5:01 AMCanaccord Genuity Group Reiterates "Buy" Rating for Taysha Gene Therapies (NASDAQ:TSHA)americanbankingnews.com - March 23 at 3:24 AMTaysha Gene Therapies (NASDAQ:TSHA) Trading Up 3.2% After Analyst Upgradeamericanbankingnews.com - March 23 at 2:40 AMTaysha Gene Therapies (NASDAQ:TSHA) PT Raised to $7.00americanbankingnews.com - March 22 at 6:22 AMTaysha Gene Therapies (NASDAQ:TSHA) Sees Large Volume Increase After Analyst Upgradeamericanbankingnews.com - March 22 at 3:52 AMComparing Bavarian Nordic A/S (OTCMKTS:BVNRY) and Taysha Gene Therapies (NASDAQ:TSHA)americanbankingnews.com - March 22 at 2:14 AMTaysha Gene Therapies, Inc. (TSHA) Q4 2023 Earnings Call Transcriptseekingalpha.com - March 21 at 6:44 PMTaysha Gene Therapies (NASDAQ:TSHA) Earns Buy Rating from Canaccord Genuity Groupmarketbeat.com - March 21 at 11:48 AMTaysha Gene Therapies (NASDAQ:TSHA) Sees Strong Trading Volume After Analyst Upgrademarketbeat.com - March 21 at 10:28 AMBuy Rating on Taysha Gene Therapies Anchored by Promising TSHA-102 Clinical Data and Upcoming Pediatric Study Catalystsmarkets.businessinsider.com - March 21 at 8:29 AMTaysha Gene Therapies Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 21 at 8:29 AMChardan Capital Raises Taysha Gene Therapies (NASDAQ:TSHA) Price Target to $7.00marketbeat.com - March 21 at 8:22 AMTaysha Gene Therapies (NASDAQ:TSHA) PT Raised to $7.00 at Needham & Company LLCamericanbankingnews.com - March 21 at 5:30 AMJMP Securities Reaffirms Market Outperform Rating for Taysha Gene Therapies (NASDAQ:TSHA)americanbankingnews.com - March 21 at 5:30 AMTaysha Gene Therapies' (TSHA) "Overweight" Rating Reaffirmed at Cantor Fitzgeraldamericanbankingnews.com - March 21 at 4:30 AMBuy Rating Affirmed for Taysha Gene Therapies Amid Positive Clinical Progress and Robust Financial Healthmarkets.businessinsider.com - March 21 at 3:28 AMTaysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up on Analyst Upgradeamericanbankingnews.com - March 21 at 1:50 AMTaysha Gene Therapies Shares Jump On Initial Data From First Pediatric Patient With Rare Neurodevelopmental Disordermsn.com - March 20 at 5:21 PMBuy Rating Reaffirmed for Taysha Gene Therapies Amid Clinical Progress and Financial Stabilitymarkets.businessinsider.com - March 20 at 5:21 PMWhy Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarketmsn.com - March 20 at 5:21 PMTaysha Gene Therapies jumps after early data for Rett syndrome candidatemsn.com - March 20 at 5:21 PMTaysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 20 at 5:20 PMTaysha Gene Therapies (NASDAQ:TSHA) Rating Reiterated by JMP Securitiesmarketbeat.com - March 20 at 10:39 AMTaysha Gene Therapies (NASDAQ:TSHA) Shares Gap Up After Analyst Upgrademarketbeat.com - March 20 at 10:34 AMTaysha Gene Therapies (NASDAQ:TSHA) Rating Reiterated by Cantor Fitzgeraldmarketbeat.com - March 20 at 9:18 AMNeedham & Company LLC Increases Taysha Gene Therapies (NASDAQ:TSHA) Price Target to $7.00marketbeat.com - March 20 at 8:11 AMTaysha Gene Therapies Shares Rise 32% After Data on Rett Syndrome Treatmentmarketwatch.com - March 20 at 5:48 AMTSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 19 at 10:01 PMTaysha Gene Therapies, Inc. 2023 Q4 - Results - Earnings Call Presentationseekingalpha.com - March 19 at 6:21 PMTaysha Gene Therapies: Q4 Earnings Insightsbenzinga.com - March 19 at 5:55 PMTaysha Gene Therapies Stock Soars On FY23 Results: Here's Whybenzinga.com - March 19 at 5:55 PMTaysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updatesglobenewswire.com - March 19 at 4:01 PMTaysha Gene Therapies Q4 2023 Earnings Previewmsn.com - March 18 at 9:32 PMTaysha Gene Therapies earnings preview: what Wall Street is expectingmarkets.businessinsider.com - March 18 at 4:32 PMTSHA Apr 2024 1.000 callfinance.yahoo.com - March 16 at 7:28 AMTaysha Gene Therapies (TSHA) Scheduled to Post Earnings on Tuesdaymarketbeat.com - March 15 at 12:10 PMTaysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19globenewswire.com - March 14 at 4:26 PMPolar Capital Holdings Plc Invests $8 Million in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)marketbeat.com - March 13 at 7:53 AMAdage Capital Partners GP L.L.C. Purchases New Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)marketbeat.com - March 11 at 6:42 AMSchonfeld Strategic Advisors LLC Acquires New Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)marketbeat.com - March 8 at 6:12 AMRA Capital Management L.P. Buys Shares of 18,472,503 Taysha Gene Therapies, Inc. (NASDAQ:TSHA)marketbeat.com - March 6 at 2:35 PMAcuta Capital Partners LLC Makes New Investment in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)marketbeat.com - March 3 at 11:58 AMDXCM, CDW and VRM are among after hour moversseekingalpha.com - March 1 at 10:46 PMTaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - March 1 at 5:08 PMBuy Rating Affirmed for Taysha Gene Therapies Amid Positive Rett Syndrome Program Developmentsmarkets.businessinsider.com - March 1 at 12:45 PMCitigroup Inc. Acquires Shares of 281,119 Taysha Gene Therapies, Inc. (NASDAQ:TSHA)marketbeat.com - March 1 at 4:34 AMBuy Rating Affirmed for Taysha Gene Therapies Amid Positive REVEAL Study Advancements and Strategic Intrathecal Administration Approachmarkets.businessinsider.com - February 29 at 9:20 PMTaysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndromeglobenewswire.com - February 29 at 8:00 AM Get Taysha Gene Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for TSHA and its competitors with MarketBeat's FREE daily newsletter. Email Address the most reliable asset on earth is making a comeback (Ad)Global tensions have been pushing the price of gold to all time highs… Just recently, gold peaked at a record $2,000 (and is now closer to $2,200). And there’s something else critical at play right now in the world’s largest asset. Because of these critical factors, a lot of massive investment institutions are now pumping more money into gold. And as we speak, some are even calling for a massive rally in the precious metal. And you can see how it works for FREE when you Click Here TSHA Media Mentions By Week TSHA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TSHA News Sentiment▼0.590.61▲Average Medical News Sentiment TSHA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TSHA Articles This Week▼222▲TSHA Articles Average Week Get Taysha Gene Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for TSHA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LXEO News MGTX News AVXL News JSPR News ITOS News ADPT News ALVO News IVVD News HUMA News CRBU News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TSHA) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taysha Gene Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.